Carmignac Gestion Sells 2,598 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Carmignac Gestion decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,870 shares of the medical equipment provider's stock after selling 2,598 shares during the period. Carmignac Gestion's holdings in Intuitive Surgical were worth $14,776,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Parvin Asset Management LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at approximately $26,000. Chilton Capital Management LLC lifted its stake in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Global Financial Private Client LLC lifted its stake in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the last quarter. Elite Financial Inc. purchased a new position in Intuitive Surgical in the first quarter valued at approximately $26,000. Finally, LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical in the first quarter valued at approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on ISRG shares. Zacks Research downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Wednesday. Evercore ISI increased their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Piper Sandler restated an "overweight" rating and set a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Finally, BTIG Research increased their target price on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Trading Up 1.3%

Shares of Intuitive Surgical stock traded up $6.28 during trading on Friday, hitting $476.16. The stock had a trading volume of 2,023,902 shares, compared to its average volume of 1,973,062. The firm has a market cap of $170.69 billion, a price-to-earnings ratio of 66.41, a P/E/G ratio of 4.92 and a beta of 1.59. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The business's 50-day moving average is $504.42 and its 200 day moving average is $522.06.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business's quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.78 earnings per share. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president owned 907 shares of the company's stock, valued at $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gary S. Guthart sold 7,893 shares of the stock in a transaction on Monday, July 28th. The shares were sold at an average price of $498.64, for a total value of $3,935,765.52. Following the completion of the transaction, the insider directly owned 13,187 shares in the company, valued at approximately $6,575,565.68. This represents a 37.44% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,839 shares of company stock valued at $7,896,972. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.